Signaling components of the 1α,25(OH)2D3-dependent Pdia3 receptor complex are required for Wnt5a calcium-dependent signaling

• Published in: Biochimica et biophysica acta. Molecular cell research Vol. 1843; no. 11; pp. 2365 - 2375
• Main Authors: Doroudi, Maryam, Olivares-Navarrete, Rene, Hyzy, Sharon L., Boyan, Barbara D., Schwartz, Zvi
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01-11-2014
• Subjects: 1,25-Dihydroxy vitamin D3; Costochondral cartilage growth zone chondrocytes; MC3T3-E1 osteoblast-like cells; Pdia3; PKC; Wnt5a; 1,25-Dihydroxy vitamin D3; Pdia3; PKC; MC3T3-E1 osteoblast-like cells; Wnt5a; Costochondral cartilage growth zone chondrocytes
• ISSN: 0167-4889; 1879-2596
• DOI: 10.1016/j.bbamcr.2014.06.006

Wnt5a and 1α,25(OH)2D3 are important regulators of endochondral ossification. In osteoblasts and growth plate chondrocytes, 1α,25(OH)2D3 initiates rapid effects via its membrane-associated receptor protein disulfide isomerase A3 (Pdia3) in caveolae, activating phospholipase A2 (PLA2)-activating protein (PLAA), calcium/calmodulin-dependent protein kinase II (CaMKII), and PLA2, resulting in protein kinase C (PKC) activation. Wnt5a initiates its calcium-dependent effects via intracellular calcium release, activating PKC and CaMKII. We investigated the requirement for components of the Pdia3 receptor complex in Wnt5a calcium-dependent signaling. We determined that Wnt5a signals through a CaMKII/PLA2/PGE2/PKC cascade. Silencing or blocking Pdia3, PLAA, or vitamin D receptor (VDR), and inhibition of calmodulin (CaM), CaMKII, or PLA2 inhibited Wnt5a-induced PKC activity. Wnt5a activated PKC in caveolin-1-silenced cells, but methyl-beta-cyclodextrin reduced its stimulatory effect. 1α,25(OH)2D3 reduced stimulatory effects of Wnt5a on PKC in a dose-dependent manner. In contrast, Wnt5a had a biphasic effect on 1α,25(OH)2D3-stimulated PKC activation; 50ng/ml Wnt5a caused a 2-fold increase in 1α,25(OH)2D3-stimulated PKC but higher Wnt5a concentrations reduced 1α,25(OH)2D3-stimulated PKC activation. Western blots showed that Wnt receptors Frizzled2 (FZD2) and Frizzled5 (FZD5), and receptor tyrosine kinase-like orphan receptor 2 (ROR2) were localized to caveolae. Blocking ROR2, but not FZD2 or FZD5, abolished the stimulatory effects of 1α,25(OH)2D3 on PKC and CaMKII. 1α,25(OH)2D3 membrane receptor complex components (Pdia3, PLAA, caveolin-1, CaM) interacted with Wnt5a receptors/co-receptors (ROR2, FZD2, FZD5) in immunoprecipitation studies, interactions that changed with either 1α,25(OH)2D3 or Wnt5a treatment. This study demonstrates that 1α,25(OH)2D3 and Wnt5a mediate their effects via similar receptor components and suggests that these pathways may interact.
•Wnt5a rapidly activates CaMKII, PLA2 and PKC in chondrocytes and osteoblasts.•Silencing or blocking Pdia3, PLAA or CaM inhibits Wnt5a signaling.•Blocking ROR2 inhibits 1α,25(OH)2D3-dependent PKC and CaMKII activation.•Pdia3, PLAA and CaM interact with Wnt5a receptors.•1α,25(OH)2D3 and Wnt5a competition may balance proliferation vs. differentiation.